BusinessZuora Recognized as a Global Leader in the First IDC MarketScape for Subscription Relationship ManagementBy Nasdaq OMXNov 27, 2017, 3:00 PM UTC
BusinessEsperion Completes Patient Enrollment in Global Pivotal Phase 3 Program for Bempedoic AcidBy Nasdaq OMXOct 2, 2017, 8:30 PM UTC
BusinessEsperion to Present at the 35th Annual J.P. Morgan Healthcare ConferenceBy Nasdaq OMXJan 4, 2017, 10:00 PM UTC
BusinessEsperion Therapeutics to Present at the Stifel 2016 Healthcare ConferenceBy Nasdaq OMXNov 9, 2016, 9:30 PM UTC
BusinessEsperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 3, 2016, 8:06 PM UTC
BusinessEsperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 3, 2016, 8:06 PM UTC
BusinessBempedoic Acid Global Phase 3 Clinical Program to Include Patients on Any Statin at Any DoseBy Nasdaq OMXOct 13, 2016, 11:30 AM UTC
